Hemodialysis Vascular Graft

Hemodialysis Vascular Graft Market Outlook

The global Hemodialysis Vascular Graft Market is projected to reach approximately USD 1.5 billion by the year 2035, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2035. The increasing prevalence of kidney diseases, alongside a rising geriatric population and the escalating demand for renal replacement therapies, are key growth factors driving this market. Additionally, advancements in surgical techniques and materials are also contributing significantly to market expansion by enhancing the efficiency and longevity of vascular grafts. The rising awareness and adoption of hemodialysis treatments, coupled with favorable reimbursement policies in many regions, are further propelling the market. These factors collectively create a conducive environment for innovations and improvements in hemodialysis vascular graft technologies, which is likely to benefit the overall market landscape.

Growth Factor of the Market

The growth of the Hemodialysis Vascular Graft Market can be attributed to several factors. Firstly, the increasing incidence of chronic kidney diseases (CKD) necessitates effective renal replacement therapy options, including hemodialysis, thus driving the demand for vascular grafts. Secondly, advancements in biomaterials and surgical procedures are enhancing the functionality and longevity of these grafts, making them more appealing to both healthcare providers and patients. Thirdly, the aging global population is more susceptible to chronic diseases, which is expected to increase the demand for hemodialysis and the corresponding vascular devices. Additionally, the expansion of healthcare infrastructure in emerging economies is expected to provide a significant boost to the market, as more patients gain access to necessary treatments. Lastly, ongoing research and development activities in the field of vascular graft technology aim to improve patient outcomes, further fueling the market growth.

Key Highlights of the Market

• The market is expected to witness a substantial growth rate of 5.9% CAGR from 2025 to 2035.
• Artificial grafts are anticipated to dominate the market due to their widespread use in hemodialysis procedures.
• North America holds the largest market share owing to advanced healthcare facilities and high adoption rates of dialysis treatments.
• Emerging economies in Asia Pacific are identified as potential growth markets due to rising healthcare expenditure.
• Technological advancements in vascular graft materials are expected to foster innovation in the product offerings.

By Product Type

Synthetic Vascular Grafts:

Synthetic vascular grafts are widely utilized in the hemodialysis process due to their durability and ease of use. These grafts are manufactured from materials like polytetrafluoroethylene (PTFE) and polyester, offering high biocompatibility and resistance to clot formation. The growing trend towards outpatient hemodialysis procedures is promoting the adoption of synthetic vascular grafts, as they can be implanted easily and are less prone to infection. Furthermore, advancements in graft coatings and the design of synthetic grafts are enhancing their effectiveness in facilitating blood flow, thus driving their increased demand in both hospitals and outpatient surgical centers.

Biological Vascular Grafts:

Biological vascular grafts are derived from human or animal tissues, offering significant advantages in terms of biocompatibility and reduced rejection rates. These grafts are particularly beneficial for patients with a history of complications related to synthetic grafts. The market for biological vascular grafts is expected to expand as healthcare professionals increasingly recognize the benefits of using biologically-derived materials, which can integrate more seamlessly with the patient’s own tissues. Additionally, as the need for personalized medicine grows, biological grafts present an attractive option due to their natural composition and lower risk of complications. However, the relatively higher cost and shorter lifespan of these grafts compared to synthetic options may pose challenges to their widespread adoption.

Biosynthetic Vascular Grafts:

Biosynthetic vascular grafts represent a hybrid approach that combines synthetic and biological materials to achieve enhanced performance and biocompatibility. These grafts are designed to offer the strength and durability of synthetic materials while also promoting cellular ingrowth and healing. As research continues to uncover the benefits of these innovative grafts, their market share is expected to grow significantly. They are particularly appealing for demanding applications like hemodialysis and coronary bypass procedures, where both durability and biocompatibility are essential. The ongoing innovation in biosynthetic graft technologies, including advancements in material science and surface modification techniques, is likely to further propel their adoption in clinical settings.

By Application

Hemodialysis:

Hemodialysis is the primary application of vascular grafts, accounting for a substantial share of the market. The increasing prevalence of end-stage renal disease (ESRD) worldwide is driving the demand for hemodialysis, necessitating effective vascular access solutions. Vascular grafts play a crucial role in establishing reliable blood vessels for dialysis, ensuring that patients receive consistent and effective treatment. As the global population ages and the incidence of diabetes and hypertension rises, the demand for hemodialysis vascular grafts is expected to soar. Continuous improvements in graft materials and designs are enhancing patient outcomes and satisfaction, further solidifying hemodialysis as a key market driver.

Coronary Artery Bypass Surgery:

Coronary artery bypass surgery (CABG) also utilizes vascular grafts to reroute blood flow around blocked arteries. The growing prevalence of coronary artery disease (CAD) is promoting the need for surgical interventions, thus increasing the demand for grafts. Surgeons often prefer using grafts made from synthetic or biological materials for CABG procedures due to their reliability and long-term patency. As surgical techniques evolve and become less invasive, the market for vascular grafts used in CABG procedures is expected to grow. Furthermore, the development of novel graft materials specifically designed for cardiac applications is likely to enhance the overall performance and outcomes of these procedures.

Peripheral Vascular Bypass Surgery:

Peripheral vascular bypass surgery involves the use of vascular grafts to treat conditions such as peripheral artery disease (PAD). As the prevalence of PAD increases, driven by factors such as smoking, obesity, and aging, the demand for effective treatment solutions is also rising. Vascular grafts are employed to bypass blocked arteries, restoring adequate blood flow to the limbs. The adoption of minimally invasive surgical techniques is further promoting the use of vascular grafts in peripheral bypass surgeries, as they reduce recovery times and improve patient satisfaction. Innovations in graft technology are enhancing the durability and effectiveness of these grafts, driving market growth in this segment.

Aneurysm Repair:

Aneurysm repair procedures also rely on vascular grafts to reinforce weakened blood vessels and restore normal blood flow. The increasing incidence of vascular conditions leading to aneurysms necessitates effective surgical solutions, which in turn, drives the demand for grafts. Vascular surgeons are increasingly opting for advanced graft materials that provide flexibility and resistance to rupture. The growing awareness of vascular health and the importance of early diagnosis are contributing to the market for aneurysm repair grafts. Additionally, the integration of imaging technologies with graft procedures is enhancing the precision and success rates of aneurysm repairs, further boosting this market segment.

Others:

Besides the aforementioned applications, vascular grafts are also used in various other surgical procedures. These may include tumor resections, trauma repairs, and other vascular reconstruction surgeries. The versatility of vascular grafts allows them to be deployed in diverse clinical settings, catering to varying surgical needs. As innovations in graft technology continue to evolve, the range of applications is likely to expand further. The rising trend of personalized medicine and tailored surgical solutions will definitely drive the adoption of vascular grafts in other surgical applications, thereby contributing to overall market growth.

By Material

Polyester:

Polyester has been a traditional choice for manufacturing vascular grafts due to its excellent mechanical properties and durability. Grafts made from polyester are widely used in various surgical applications, particularly in hemodialysis and coronary artery bypass surgeries. The material exhibits good tensile strength and biocompatibility, making it suitable for long-term implantation. However, polyester grafts may be associated with a higher rate of thrombosis compared to other materials. Advances in surface modifications and drug-eluting technologies are being explored to enhance the performance of polyester vascular grafts, making them more competitive in the current market.

Polytetrafluoroethylene (PTFE):

Polytetrafluoroethylene (PTFE) is a highly favored material for vascular grafts primarily due to its excellent biocompatibility and low friction surface, which minimizes clot formation. PTFE grafts are particularly well-suited for hemodialysis applications, where reliable access to the bloodstream is critical. The long-term patency rates associated with PTFE grafts are contributing to their widespread use in clinical settings. Additionally, PTFE’s resistance to chemical and environmental degradation ensures that these grafts maintain their integrity over extended periods. Continuous innovations are being made in PTFE graft coatings to further enhance their performance, thereby solidifying their position in the vascular graft market.

Polyurethane:

Polyurethane is gaining traction in the vascular graft market due to its superior elasticity and biocompatibility. Unlike traditional synthetic materials, polyurethane offers the ability to mimic the natural properties of blood vessels, making it a favorable choice in various surgical applications. The adaptability of polyurethane allows for the design of grafts that can accommodate a wide range of blood flow conditions, which is particularly beneficial in hemodialysis and peripheral vascular surgeries. Continued research into enhancing the mechanical properties and surface characteristics of polyurethane grafts is likely to foster greater adoption and application in the healthcare sector.

Biological Materials:

Biological materials for vascular grafts are increasingly recognized for their biocompatibility and potential for improved healing outcomes. Derived from human or animal tissues, these grafts are designed to integrate well with the patient's own biological system, reducing the risk of rejection. The market for biological materials in vascular grafts is expanding as clinicians seek to provide more effective and personalized treatment options. However, challenges such as sourcing, processing, and storage of biological grafts may limit their widespread use. Ongoing advancements in tissue engineering and regenerative medicine are expected to enhance the viability and availability of biological vascular grafts in the future.

Others:

In addition to the aforementioned materials, various other materials are being explored for the development of vascular grafts. These may include innovative composites and hybrid materials that combine the beneficial properties of different substances to enhance graft performance. The exploration of biodegradable materials for temporary vascular grafts is also gaining attention, offering potential benefits in reducing long-term complications associated with permanent implants. As researchers continue to innovate and explore new approaches in vascular graft technology, the market for alternative materials is anticipated to grow, providing healthcare professionals with a wider array of options to meet patient needs.

By Polytetrafluoroethylene

Expanded PTFE (ePTFE):

Expanded polytetrafluoroethylene (ePTFE) is a specialized form of PTFE that has gained popularity in vascular graft applications due to its unique properties. The expansion process creates a porous structure that promotes tissue ingrowth, enhancing graft integration and stability. ePTFE grafts are particularly advantageous in hemodialysis procedures, as they maintain flexibility while resisting occlusion. The increasing demand for grafts that offer both durability and biocompatibility is driving the adoption of ePTFE in surgical settings. Continuous research and development are focused on optimizing ePTFE graft designs to further improve patient outcomes and long-term graft performance.

PTFE Coated Grafts:

PTFE coated grafts combine the benefits of traditional graft materials with the advanced properties of PTFE, providing a versatile solution for various surgical applications. The coating helps to prevent thrombosis and improves biocompatibility, making these grafts suitable for high-risk patients requiring hemodialysis or vascular bypass surgery. The coatings can also be tailored to release therapeutic agents, further enhancing the graft’s performance. As healthcare providers increasingly prioritize patient safety and long-term success, PTFE coated grafts are expected to see rising demand in the vascular graft market.

By User

Hospitals:

Hospitals are the largest end-user segment in the hemodialysis vascular graft market due to their role as primary treatment centers for patients with renal diseases. With a significant number of hemodialysis procedures performed in hospital settings, the demand for high-quality vascular grafts is substantial. Hospitals are also increasingly adopting advanced surgical techniques and materials, which further drives the need for innovative graft products. The growing focus on improving patient outcomes and reducing complication rates is pushing hospitals to invest in cutting-edge graft technologies, which will likely sustain growth in this segment.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are emerging as significant players in the hemodialysis vascular graft market. These centers provide outpatient surgical procedures, offering patients convenience and reduced recovery times compared to traditional hospital settings. The rising trend of outpatient surgeries is paving the way for the increased use of vascular grafts in ASCs. Additionally, the cost-effectiveness associated with ASCs is appealing to both patients and healthcare providers, making them an attractive option for various surgeries, including hemodialysis access. As more ASCs expand their service offerings, the demand for vascular grafts is expected to grow accordingly.

Specialty Clinics:

Specialty clinics are increasingly focusing on specific areas of healthcare, such as nephrology and vascular surgery, contributing to the demand for vascular grafts in targeted treatments. These clinics are equipped with specialized knowledge and tools to provide comprehensive care for patients with renal diseases, leading to a higher utilization rate of hemodialysis grafts. The personalized treatment approach adopted by specialty clinics often results in better patient outcomes, thereby increasing the demand for advanced vascular graft technologies. The growth of specialty clinics in the healthcare landscape will likely support the expansion of the vascular graft market.

By Region

North America currently leads the global hemodialysis vascular graft market, accounting for approximately 40% of the total market share. This dominance can be attributed to the high prevalence of chronic kidney diseases and a well-established healthcare infrastructure that supports advanced surgical procedures. The growing aging population and increasing healthcare expenditures further contribute to the region's substantial market presence. Additionally, the presence of key industry players and ongoing innovations are expected to sustain North America's market position, with a projected CAGR of 5.5% through 2035. The focus on improving patient outcomes and ensuring access to quality healthcare services will continue to drive market growth in this region.

Europe is another significant market for hemodialysis vascular grafts, holding a share of approximately 30%. The European region is witnessing a rise in the incidence of kidney-related diseases, leading to increased demand for effective treatment methods, including hemodialysis. Additionally, the European healthcare system's emphasis on technological advancements and innovative treatment options is facilitating market expansion. Countries such as Germany, the UK, and France are at the forefront of this growth, driven by their robust healthcare infrastructure and availability of skilled medical professionals. As the market continues to evolve, Europe is expected to exhibit a CAGR of 6.2% during the forecast period, driven by an aging population and increased healthcare spending.

Opportunities

The hemodialysis vascular graft market is poised for numerous opportunities, particularly in emerging economies where healthcare infrastructure is rapidly improving. As populations in these regions become more aware of chronic kidney diseases and the need for effective treatment, the demand for hemodialysis solutions is likely to surge. Governments are increasingly investing in healthcare initiatives and providing better access to treatment, which is expected to create a favorable environment for the growth of the vascular graft market. Furthermore, the rising prevalence of lifestyle-related diseases, coupled with the growing aging population, presents significant opportunities for manufacturers to introduce innovative graft technologies tailored for specific patient needs. These factors combined create a positive outlook for future market expansion.

Another notable opportunity lies in the ongoing research and development efforts towards improving vascular graft technologies. Innovations in materials science, including the development of next-generation grafts with enhanced biocompatibility and reduced complication rates, are expected to drive market growth. Collaboration between academia and industry can lead to breakthroughs in graft performance, ultimately resulting in improved patient outcomes. Additionally, the integration of advanced technologies such as 3D printing and personalized medicine will further enhance the capabilities of vascular grafts, making them more adaptable to individual patient anatomies. This focus on innovation will be pivotal in shaping the future of the hemodialysis vascular graft market.

Threats

Despite the promising growth prospects, the hemodialysis vascular graft market faces several threats that could impede its expansion. One major concern is the potential for stringent regulatory requirements governing the manufacturing and approval of vascular grafts. As regulations become increasingly rigorous, manufacturers may encounter delays in product launches and increased costs associated with compliance. Additionally, the market is susceptible to fluctuations in raw material prices, which could impact the overall pricing of vascular grafts. The emergence of alternative treatment options, such as peritoneal dialysis, may also pose a threat to the hemodialysis vascular graft market as patients and healthcare providers explore various methods for renal replacement therapy.

Another significant threat to the market is the risk of complications associated with vascular graft procedures, including infections and thrombosis. Such complications can lead to negative patient outcomes, increasing the overall burden on healthcare systems and discouraging the use of vascular grafts. Furthermore, the growing trend towards minimally invasive procedures may limit the demand for traditional vascular grafts, as healthcare providers seek less invasive alternatives. Addressing these challenges will require ongoing research and innovation to improve graft designs and enhance patient safety, ensuring the long-term sustainability of the hemodialysis vascular graft market.

Competitor Outlook

• Gore Medical
• Boston Scientific Corporation
• Medtronic
• Abbott Laboratories
• Terumo Corporation
• Cook Medical
• AngioDynamics
• Bard Peripheral Vascular
• Asahi Intecc
• Cardinal Health
• JOTEC GmbH
• Fresenius Medical Care AG & Co. KGaA
• Vascular Solutions, Inc.
• Integra LifeSciences Corporation
• Biogennix

The competitive landscape of the hemodialysis vascular graft market is characterized by the presence of several established players and emerging companies. Major companies, such as Gore Medical and Medtronic, are actively involved in developing innovative graft technologies that enhance patient outcomes and expand market reach. These companies leverage their extensive research capabilities and financial resources to introduce advanced materials and designs, addressing the evolving needs of healthcare professionals and patients. Continuous product development and strategic partnerships are pivotal strategies adopted by these leading players to maintain their competitive edge and drive market growth.

In addition to established firms, several emerging companies are entering the hemodialysis vascular graft market, introducing novel solutions and technologies that challenge traditional offerings. Companies such as Biogennix and Vascular Solutions, Inc. are focusing on niche markets and developing specialized grafts that cater to specific surgical needs. By understanding market dynamics and patient requirements, these emerging players can capitalize on gaps in the market and position themselves as viable alternatives to well-known brands. The ongoing innovation and diversification of product portfolios among both established and emerging companies will continue to shape the competitive landscape.

Companies like Fresenius Medical Care AG & Co. KGaA and Abbott Laboratories play critical roles in the hemodialysis vascular graft market through their extensive product portfolios and strong distribution networks. They are known for their commitment to improving patient care and outcomes, actively investing in research and development initiatives to bring forth new and improved graft solutions. Additionally, strategic collaborations and acquisitions are common practices among key players in this market, aimed at expanding their product offerings and enhancing competitive positioning. As the demand for advanced vascular grafts continues to rise, these companies are well-positioned to capture significant market share through their innovative approaches.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Biogennix
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 JOTEC GmbH
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Asahi Intecc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Cook Medical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Gore Medical
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 AngioDynamics
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Cardinal Health
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Terumo Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Abbott Laboratories
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Bard Peripheral Vascular
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Vascular Solutions, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Integra LifeSciences Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Fresenius Medical Care AG & Co. KGaA
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Hemodialysis Vascular Graft Market, By User
    • 6.1.1 Hospitals
    • 6.1.2 Ambulatory Surgical Centers
    • 6.1.3 Specialty Clinics
  • 6.2 Hemodialysis Vascular Graft Market, By Material
    • 6.2.1 Polyester
    • 6.2.2 Polytetrafluoroethylene (PTFE)
    • 6.2.3 Polyurethane
    • 6.2.4 Biological Materials
    • 6.2.5 Others
  • 6.3 Hemodialysis Vascular Graft Market, By Application
    • 6.3.1 Hemodialysis
    • 6.3.2 Coronary Artery Bypass Surgery
    • 6.3.3 Peripheral Vascular Bypass Surgery
    • 6.3.4 Aneurysm Repair
    • 6.3.5 Others
  • 6.4 Hemodialysis Vascular Graft Market, By Product Type
    • 6.4.1 Synthetic Vascular Grafts
    • 6.4.2 Biological Vascular Grafts
    • 6.4.3 Biosynthetic Vascular Grafts

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Hemodialysis Vascular Graft Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Hemodialysis Vascular Graft market is categorized based on

By Product Type

• Synthetic Vascular Grafts
• Biological Vascular Grafts
• Biosynthetic Vascular Grafts

By Application

• Hemodialysis
• Coronary Artery Bypass Surgery
• Peripheral Vascular Bypass Surgery
• Aneurysm Repair
• Others

By Material

• Polyester
• Polytetrafluoroethylene (PTFE)
• Polyurethane
• Biological Materials
• Others

By User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Gore Medical
• Boston Scientific Corporation
• Medtronic
• Abbott Laboratories
• Terumo Corporation
• Cook Medical
• AngioDynamics
• Bard Peripheral Vascular
• Asahi Intecc
• Cardinal Health
• JOTEC GmbH
• Fresenius Medical Care AG & Co. KGaA
• Vascular Solutions, Inc.
• Integra LifeSciences Corporation
• Biogennix